Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10405 | 1000 | 30.2 | 58% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
283 | 18382 | EXPERIMENTAL HEMATOLOGY//G CSF//PLERIXAFOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BONE MARROW PURGING | Author keyword | 3 | 30% | 1% | 9 |
2 | MARROW PURGING | Author keyword | 3 | 35% | 1% | 7 |
3 | MAFOSFAMIDE | Author keyword | 2 | 19% | 1% | 11 |
4 | CYCLOPHOSPHAMIDE DERIVATIVES | Author keyword | 2 | 67% | 0% | 2 |
5 | ISOPYCNIC DENSITY CENTRIFUGATION | Author keyword | 2 | 67% | 0% | 2 |
6 | 4 HC | Author keyword | 2 | 43% | 0% | 3 |
7 | CLONOGENIC LEUKEMIC CELLS | Author keyword | 1 | 100% | 0% | 2 |
8 | PHARMACOLOGICAL PURGING | Author keyword | 1 | 100% | 0% | 2 |
9 | DENSITY PERTURBATION | Author keyword | 1 | 27% | 0% | 4 |
10 | GORALATIDE | Author keyword | 1 | 40% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BONE MARROW PURGING | 3 | 30% | 1% | 9 | Search BONE+MARROW+PURGING | Search BONE+MARROW+PURGING |
2 | MARROW PURGING | 3 | 35% | 1% | 7 | Search MARROW+PURGING | Search MARROW+PURGING |
3 | MAFOSFAMIDE | 2 | 19% | 1% | 11 | Search MAFOSFAMIDE | Search MAFOSFAMIDE |
4 | CYCLOPHOSPHAMIDE DERIVATIVES | 2 | 67% | 0% | 2 | Search CYCLOPHOSPHAMIDE+DERIVATIVES | Search CYCLOPHOSPHAMIDE+DERIVATIVES |
5 | ISOPYCNIC DENSITY CENTRIFUGATION | 2 | 67% | 0% | 2 | Search ISOPYCNIC+DENSITY+CENTRIFUGATION | Search ISOPYCNIC+DENSITY+CENTRIFUGATION |
6 | 4 HC | 2 | 43% | 0% | 3 | Search 4+HC | Search 4+HC |
7 | CLONOGENIC LEUKEMIC CELLS | 1 | 100% | 0% | 2 | Search CLONOGENIC+LEUKEMIC+CELLS | Search CLONOGENIC+LEUKEMIC+CELLS |
8 | PHARMACOLOGICAL PURGING | 1 | 100% | 0% | 2 | Search PHARMACOLOGICAL+PURGING | Search PHARMACOLOGICAL+PURGING |
9 | DENSITY PERTURBATION | 1 | 27% | 0% | 4 | Search DENSITY+PERTURBATION | Search DENSITY+PERTURBATION |
10 | GORALATIDE | 1 | 40% | 0% | 2 | Search GORALATIDE | Search GORALATIDE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 4 HYDROPEROXYCYCLOPHOSPHAMIDE | 8 | 22% | 3% | 33 |
2 | MAFOSFAMIDE | 5 | 30% | 1% | 14 |
3 | MAFOSFAMIDE ASTA Z 7557 | 3 | 57% | 0% | 4 |
4 | ASTA Z 7654 | 3 | 100% | 0% | 3 |
5 | INVITRO TREATMENT | 2 | 30% | 1% | 6 |
6 | ASTA Z 7557 | 1 | 25% | 1% | 5 |
7 | ASTAZ7557 INN MAFOSFAMIDE | 1 | 38% | 0% | 3 |
8 | CD2F1 MICE | 1 | 100% | 0% | 2 |
9 | TETRAMERIC ANTIBODY COMPLEXES | 1 | 50% | 0% | 2 |
10 | BNML | 1 | 33% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
AUTOLOGOUS BONE-MARROW TRANSPLANTATION - CURRENT STATUS AND FUTURE-DIRECTIONS | 1989 | 177 | 97 | 25% |
STEM-CELL PURGING - AN INTRIGUING DILEMMA | 1995 | 19 | 57 | 35% |
THE BN ACUTE MYELOCYTIC-LEUKEMIA (BNML) (A RAT MODEL FOR STUDYING HUMAN ACUTE MYELOCYTIC-LEUKEMIA (AML)) | 1990 | 42 | 85 | 46% |
Delivering cellular therapies: Lessons learned from ex vivo culture and clinical applications of hematopoietic cells | 2007 | 7 | 22 | 32% |
PHARMACOLOGICAL BONE-MARROW PURGING IN AUTOLOGOUS TRANSPLANTATION - FOCUS ON THE CYCLOPHOSPHAMIDE DERIVATIVES | 1993 | 8 | 131 | 56% |
AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA | 1992 | 9 | 40 | 53% |
AUTOLOGOUS BONE-MARROW TRANSPLANTATION | 1989 | 49 | 38 | 34% |
AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADULT ACUTE-LEUKEMIA | 1993 | 9 | 93 | 40% |
Purging: The separation of normal from malignant cells for autologous transplantation | 1996 | 15 | 119 | 20% |
DEVELOPMENTS IN PURGING IN AUTOTRANSPLANTATION | 1993 | 12 | 183 | 29% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PAEDIAT ONCOL BMT | 1 | 50% | 0.1% | 1 |
2 | SEKT HAMATOL ONKOL | 1 | 50% | 0.1% | 1 |
3 | AIDRC | 0 | 33% | 0.1% | 1 |
4 | POLIKLIN S HAMATOL ONKOL | 0 | 25% | 0.1% | 1 |
5 | TATA MEM RURAL CANC PROJECT | 0 | 25% | 0.1% | 1 |
6 | BONE MARROW TRANSPLANT SECT | 0 | 20% | 0.1% | 1 |
7 | EXPTL GERONTOL | 0 | 20% | 0.1% | 1 |
8 | SPECIAL MED EDUC PROGRAMS | 0 | 20% | 0.1% | 1 |
9 | UNITE INGN CELLULAIRE | 0 | 20% | 0.1% | 1 |
10 | CELL BIOL RADIAT ST S CELL BIOL | 0 | 17% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000156650 | MEROCYANINE 540//BIOMED SPECT//MEROCYANINE 540 MC540 |
2 | 0.0000119557 | TOTAL BODY IRRADIATION//TOTAL MARROW IRRADIATION//OCULAR GRAFT VERSUS HOST DISEASE |
3 | 0.0000117941 | PLERIXAFOR//LARGE VOLUME LEUKAPHERESIS//STEM CELL MOBILIZATION |
4 | 0.0000116198 | LEUKEMIC BLAST PROGENITORS//L CFU//500 SHERBOURNE ST |
5 | 0.0000111317 | T CELL ASSOCIATED ANTIGENS//CD8 ANTIGEN//B CELL NON HODGKIN LYMPHOMA B NHL |
6 | 0.0000098601 | MHC NONRESTRICTED CYTOTOXICITY//HISTAMINE DIHYDROCHLORIDE//BOWYER ONCOL |
7 | 0.0000087874 | ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML |
8 | 0.0000081018 | COUNTERFLOW CENTRIFUGATION ELUTRIATION//COUNTERFLOW CENTRIFUGAL ELUTRIATION//DUTTAPHRYNUS HIMALAYANUS |
9 | 0.0000080029 | LYMPHOCYTE RECOVERY//IMMUNE RECONSTITUTION//BMT RECIPIENTS |
10 | 0.0000077507 | PASSENGER LYMPHOCYTE SYNDROME//ABO INCOMPATIBLE BMT//ABO MISMATCH |